12:00 AM
Mar 15, 1999
 |  BC Week In Review  |  Company News  |  Other News

Enzon Inc. enabling technology news

ENZN formed SCA Ventures as a wholly-owned subsidiary to commercialize its Single-Chain Antigen-Binding (SCA) protein...

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >